Gould Asset Management LLC Bristol Myers Squibb CO Transaction History

Gould Asset Management LLC

$464 Million
Q3 2024

A detailed history of Gould Asset Management LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Gould Asset Management LLC holds 7,170 shares of BMY stock, worth $417,509. This represents 0.08% of its overall portfolio holdings.

Number of Shares

7,170

Previous 7,170 -0.0%

Holding current value

$417,509

Previous $297,000 24.92%

% of portfolio

0.08%

Previous 0.07%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 05, 2024	SELL	$40.25 - $52.99 $4,025 - $5,299	-100 Reduced 1.38%	7,170 $297,000
Q4 2023 Feb 02, 2024	SELL	$48.48 - $57.85 $109,080 - $130,162	-2,250 Reduced 23.63%	7,270 $373,000
Q3 2023 Oct 23, 2023	BUY	$57.89 - $64.73 $57,890 - $64,730	1,000 Added 11.74%	9,520 $552,000
Q2 2023 Aug 07, 2023	SELL	$63.71 - $70.74 $11,786 - $13,086	-185 Reduced 2.13%	8,520 $544,000
Q4 2022 Feb 08, 2023	SELL	$68.48 - $81.09 $30,473 - $36,085	-445 Reduced 4.86%	8,705 $626,000
Q3 2022 Nov 14, 2022	SELL	$0.13 - $76.84 $42 - $24,973	-325 Reduced 3.43%	9,150 $650,000
Q2 2022 Aug 10, 2022	BUY	$72.62 - $79.98 $41,756 - $45,988	575 Added 6.46%	9,475 $730,000
Q1 2022 May 13, 2022	SELL	$61.48 - $73.72 $614 - $737	-10 Reduced 0.11%	8,900 $650,000
Q4 2021 Feb 02, 2022	BUY	$53.63 - $62.52 $55,507 - $64,708	1,035 Added 13.14%	8,910 $556,000
Q3 2021 Nov 09, 2021	SELL	$59.17 - $69.31 $140,469 - $164,541	-2,374 Reduced 23.16%	7,875 $466,000
Q2 2021 Aug 05, 2021	BUY	$61.91 - $67.42 $75,530 - $82,252	1,220 Added 13.51%	10,249 $685,000
Q1 2021 May 07, 2021	SELL	$59.34 - $66.74 $94,647 - $106,450	-1,595 Reduced 15.01%	9,029 $570,000
Q4 2020 Feb 02, 2021	BUY	$57.74 - $65.43 $75,639 - $85,713	1,310 Added 14.06%	10,624 $659,000
Q3 2020 Nov 05, 2020	BUY	$57.43 - $63.64 $17,229 - $19,092	300 Added 3.33%	9,314 $562,000
Q2 2020 Aug 05, 2020	BUY	$54.82 - $64.09 $21,928 - $25,636	400 Added 4.64%	9,014 $530,000
Q1 2020 Apr 23, 2020	SELL	$46.4 - $67.43 $43,105 - $62,642	-929 Reduced 9.73%	8,614 $480,000
Q4 2019 Jan 17, 2020	SELL	$49.21 - $64.19 $59,790 - $77,990	-1,215 Reduced 11.29%	9,543 $613,000
Q3 2019 Nov 12, 2019	SELL	$42.77 - $50.71 $43,668 - $51,774	-1,021 Reduced 8.67%	10,758 $546,000
Q2 2019 Jul 31, 2019	BUY	$44.62 - $49.34 $43,058 - $47,613	965 Added 8.92%	11,779 $534,000
Q1 2019 May 07, 2019	SELL	$45.12 - $53.8 $4,512 - $5,380	-100 Reduced 0.92%	10,814 $516,000
Q3 2018 Nov 08, 2018	SELL	$55.19 - $62.25 $4,691 - $5,291	-85 Reduced 0.77%	10,914 $678,000
Q2 2018 Aug 13, 2018	BUY	$50.53 - $62.98 $5,053 - $6,298	100 Added 0.92%	10,999 $609,000
Q1 2018 May 04, 2018	BUY	$59.92 - $68.98 $11,984 - $13,796	200 Added 1.87%	10,899 $689,000
Q4 2017 Feb 09, 2018	BUY	$59.94 - $65.35 $17,982 - $19,605	300 Added 2.88%	10,699 $656,000
Q3 2017 Nov 09, 2017	BUY	$55.23 - $63.74 $574,336 - $662,832	10,399	10,399 $663,000

Others Institutions Holding BMY

# of Institutions

2,533

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $124B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gould Asset Management LLC , based on Form 13F filings with the SEC.

News

Stay updated on Gould Asset Management LLC with notifications on news.

Account

Gould Asset Management LLC Bristol Myers Squibb CO Transaction History